Major Bleeding Risk in Atrial Fibrillation Patients Co-Medicated With Non-Vitamin K Oral Anticoagulants and Antipsychotics

Major Bleeding Risk in Atrial Fibrillation Patients Co-Medicated With Non-Vitamin K Oral Anticoagulants and Antipsychotics

Major bleeding risks associated with non-vitamin K oral anticoagulants (NOACs) used with and without concurrent antipsychotics in patients with non-valvular atrial fibrillation (AF) were assessed. A total of 98,863 patients with non-valvular AF receiving at least one NOAC prescription from Taiwan’s...

Full description

Bibliographic Details
Main Authors: Chiung-Mei Chen, Kuo-Hsuan Chang, Chun-Li Wang, Hui-Tzu Tu, Yu-Tung Huang, Hsiu-Chuan Wu, Chien-Hung Chang, Shang-Hung Chang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Pharmacology
Subjects:
major bleeding risk
non-vitamin K oral anticoagulant
antipsychotics
non-valvular atrial fibrillation
combined medication
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.819878/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.819878/full

Similar Items